Company News - Press Releases - Events - Publications

Innovative Fragment Library Concept Allows Identification of New Lead Compounds for Immediate Pre-Clinical Use; Bicoll and Crelux to Market Co-Developed New Fragment Service Platform

Munich (Germany) – December 7, 2011 – BICOLL announced today that it has entered into a sales agreement with CRELUX, a high quality protein and crystallography service provider. The two companies will jointly market their new platform technology to identify a broad range of small active bio-molecules for further (pre-)clinical development. CRELUX will base the establishment of new targets for its fragment based screening services on BICOLL’s unique proprietary small molecule natural product library BILOBAC N. BICOLL’s pooled and fractionated small molecule collections derive from endemic Asian plants that have a proven track record in the identification of new lead compounds. Some of which have already entered preclinical development status.

Questions? Get in touch!

We would love talking to you:

Bicoll GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried
+49 (0)89 820 106 30

This Site uses cookies, which could include third-party cookies, to ensure its technical functioning and which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies. If you want to learn more about our Privacy Policy click here.